Hoffman, White Featured in Texas Lawbook’s Coronavirus FAQs Feature
March 20, 2020
The Texas Lawbook
Partner Carrie Hoffman and Senior Counsel Taylor White were featured in The Texas Lawbook article, “Coronavirus Client Service: FAQ Edition,” which provided answers to some of the most frequently answered questions that TLB is hearing amid the coronavirus pandemic. The article drew from Foley’s Coronavirus Resource Center and provided advice to questions including:
- If I decide to take employees’ temperatures or other health screening procedures, does the person administering the screening need to be a medical professional?
- If I implement a voluntary work from home policy for the next several weeks or a month for employees who are able to work remotely, do I need to reimburse them for expenses?
- We recently received products that were shipped from one of the countries that the centers for disease control has designated “Level 3.” My employees [or customers] are refusing to handle the product. What should I do?
- Can I Discipline Employees for not Covering Their Mouths when Coughing/Sneezing or for Failing to Regularly Use Provided Hand Sanitizers?
(Subscription required)
People
Related News
March 13, 2026
In the News
Chris Babcock and Chris Converse on Wave of Companies Moving to Texas
Foley & Lardner LLP partners Chrisopher Babcock and Chris Converse commented on the widening trend of companies reincorporating to Texas in the Houston Business Journal article, “Texas law changes could spark wave of corporate redomestication proposals."
March 12, 2026
In the News
Louis Lehot Explores M&A's Growing Blitzhire Phenomenon
Foley & Lardner LLP partner Louis Lehot authors article on the emergence of blitzhires in the Mergers & Acquisitions article, “Blitzhires: The New Fast-Moving M&A Deal.”
March 10, 2026
In the News
Aaron Maguregui Shares Insights on Shadow AI Risks in Health Care
Foley & Lardner LLP partner Aaron Maguregui was quoted in the Part B News article, “Do you need AI policy? Experts suggest guardrails as 'shadow AI' spreads,” discussing the emerging risks of unsanctioned 'shadow AI' use by clinicians and the need to establish robust AI governance.